Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Walker

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Hormone Research|January 1, 1989
Zoladex in advanced breast cancerJ F Robertson, R I Nicholson, K J Walker, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic modelK J Walker, A J Larsson, R A Zabinski, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1996
The concentration-independent effect of monoexponential and biexponential decay in vancomycin concentrations on the killing of Staphylococcus aureus under aerobic and anaerobic conditionsA J Larsson, K J Walker, J K Raddatz, et al.
British Journal of Cancer|October 1, 1991
Influence of the antioestrogen tamoxifen on normal breast tissueK J Walker, J M Price-Thomas, W Candlish, et al.
The British Journal of Surgery|December 1, 1989
Combined endocrine effects of LHRH agonist (Zoladex) and tamoxifen (Nolvadex) therapy in premenopausal women with breast cancerJ F Robertson, K J Walker, R I Nicholson, et al.
Journal of Clinical Pharmacology|December 1, 1992
Pharmacotherapy and pharmacodynamics in the management of bacterial infectionJ C Rotschafer, R A Zabinski, K J Walker, et al.
Journal of Wound Care|December 7, 2016
LettersS Cudder, K J Walker, J Allen, et al.
The Journal of Endocrinology|November 1, 1986
Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancerK J Walker, A Turkes, M R Williams, et al.
British Journal of Cancer|May 1, 1986
The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancerM R Williams, K J Walker, A Turkes, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Heterogeneity of oestrogen receptor expression in normal and malignant breast tissueK J Walker, R A McClelland, W Candlish, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Hormone Research|January 1, 1989
Zoladex in advanced breast cancerJ F Robertson, R I Nicholson, K J Walker, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic modelK J Walker, A J Larsson, R A Zabinski, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1996
The concentration-independent effect of monoexponential and biexponential decay in vancomycin concentrations on the killing of Staphylococcus aureus under aerobic and anaerobic conditionsA J Larsson, K J Walker, J K Raddatz, et al.
British Journal of Cancer|October 1, 1991
Influence of the antioestrogen tamoxifen on normal breast tissueK J Walker, J M Price-Thomas, W Candlish, et al.
The British Journal of Surgery|December 1, 1989
Combined endocrine effects of LHRH agonist (Zoladex) and tamoxifen (Nolvadex) therapy in premenopausal women with breast cancerJ F Robertson, K J Walker, R I Nicholson, et al.
Journal of Clinical Pharmacology|December 1, 1992
Pharmacotherapy and pharmacodynamics in the management of bacterial infectionJ C Rotschafer, R A Zabinski, K J Walker, et al.
Journal of Wound Care|December 7, 2016
LettersS Cudder, K J Walker, J Allen, et al.
The Journal of Endocrinology|November 1, 1986
Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancerK J Walker, A Turkes, M R Williams, et al.
British Journal of Cancer|May 1, 1986
The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancerM R Williams, K J Walker, A Turkes, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Heterogeneity of oestrogen receptor expression in normal and malignant breast tissueK J Walker, R A McClelland, W Candlish, et al.
Pageof 5